The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
- 31 March 2012
- journal article
- Published by Elsevier BV in Neuroscience Research
- Vol. 72 (3), 236-242
- https://doi.org/10.1016/j.neures.2011.12.006
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced DyskinesiaPLOS ONE, 2010
- Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic‐AMP/protein kinase A pathway in midbrain dopamine neuronsThe Journal of Physiology, 2010
- Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2Neurochemistry International, 2009
- Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurinProceedings of the National Academy of Sciences of the United States of America, 2008
- Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptorsExperimental Neurology, 2007
- Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus MonkeysThe Journal of pharmacology and experimental therapeutics, 2007
- Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1αNeuron, 2007
- Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunitProceedings of the National Academy of Sciences of the United States of America, 2007
- The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinProceedings of the National Academy of Sciences of the United States of America, 2006
- DARPP-32 Is a Robust Integrator of Dopamine and Glutamate SignalsPLoS Computational Biology, 2006